✦ LIBER ✦

Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency

✍ Scribed by Melvin Berger; Paul J. Pinciaro; Arthur Althaus; Mark Ballow; Akhilesh Chouksey; James Moy; Hans Ochs; Mark Stein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, Safety and Tolerability of a N

✍ Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 443 KB

Efficacy and Tolerability of an Argentin

✍ S. Krasovec; A. Ornani; M. Oleastro; S. Rosenzweig; A. Roy; L. Perez; G. Campos; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 175 KB

Safety and Efficacy of Privigen®, a Nove

✍ Mark R. Stein; Robert P. Nelson; Joseph A. Church; Richard L. Wasserman; Michael 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 166 KB

A Multicenter, Prospective, Open Label,

✍ Melvin Berger; The Flebogamma® 5% DIF Investigators 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 126 KB

Efficacy, Safety, and Pharmacokinetics o

✍ Richard L. Wasserman; Isaac Melamed; Lisa Kobrynski; Steven D. Strausbaugh; Mark 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 213 KB